NASDAQ
06.01.25
22:00 Uhr
1,370 US-Dollar
0,000
0,00 %
0,00 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | IceCure Medical erfüllt wieder Nasdaq-Anforderungen | - | Investing.com Deutsch | ||
| Mo | IceCure Medical regains Nasdaq compliance | 2 | Investing.com | ||
| Mo | IceCure Medical regains compliance with Nasdaq | 1 | Seeking Alpha | ||
| Mo | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| Fr | IceCure earns European patent win for next-gen cryoablation tech | 1 | MassDevice | ||
| Fr | IceCure Nicks Up on European OK for Connector | 1 | Baystreet.ca | ||
| ICECURE MEDICAL Aktie jetzt für 0€ handeln | |||||
| Fr | IceCure Medical: European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation Technology | 57 | PR Newswire | XSense system's innovative cryogenic connector technology designed to improve safety and maintain the integrity of cryogen used in the cryoablation procedure
CAESAREA... ► Artikel lesen | |
| 30.12.24 | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 05.12.24 | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 26.11.24 | IceCure Medical GAAP EPS of $0.22 , revenue of $2.41M | 1 | Seeking Alpha | ||
| 26.11.24 | IceCure Medical reports 36% sales growth in first nine months of 2024 | 1 | Seeking Alpha | ||
| 26.11.24 | Icecure Medical Earnings Review: Q3 Summary | 1 | Benzinga.com | ||
| 26.11.24 | IceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense Cryoablation | 122 | PR Newswire | FDA Marketing Authorization Decision on Early Stage-Low Risk Breast Cancer Expected in Q1 2025
Conference call to be held today at 10:00 am Eastern Time
CAESAREA... ► Artikel lesen | |
| 25.11.24 | What to Expect from Icecure Medical's Earnings | 1 | Benzinga.com | ||
| 25.11.24 | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 08.11.24 | IceCure gets favorable FDA AdCom vote for ProSense System | 2 | Seeking Alpha | ||
| 08.11.24 | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 05.11.24 | IceCure Medical Ltd. - F-1/A, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 21.10.24 | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.10.24 | IceCure Medical: IceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation System | 75 | PR Newswire | Innovative cryogenic system connector technology designed to improve usability and maintain the integrity of cryogen used in the cryoablation procedure
CAESAREA, Israel, Oct. 21, 2024 /PRNewswire/... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
51 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 6,356 | +0,68 % | emeis announces €251m in disposals of real estate and operating assets since the beginning of October | Nearly €900 million in disposals completed since mid-2022 or secured to date Disposal of activities in Chile and the Czech Republic
Regulatory News:
emeis (Paris:EMEIS) today announced... ► Artikel lesen | |
| NANO-X IMAGING | 9,970 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| BUTTERFLY NETWORK | 4,265 | 0,00 % | BFLY-Aktie erreicht 52-Wochen-Hoch bei 3,78 US-Dollar | ||
| CARMAT | 1,066 | -0,93 % | CARMAT optimizes its financial structure by buying-back, for a symbolic sum of one euro, 2 million shares from Matra-Défense (Airbus group) which will be allocated to the repayment of its financial debt | Buy-back by CARMAT of 2 million shares from Airbus for a symbolic sum of 1 euro. The shares so bought-back will be allocated to the repayment of the Company's financial debt, via their... ► Artikel lesen | |
| TALKSPACE | 3,260 | 0,00 % | Talkspace More Widely Available | ||
| GOODRX | 4,540 | 0,00 % | GoodRx (NASDAQ:GDRX) Sees Strong Trading Volume - Here's Why | ||
| JOINT CORP | 10,600 | 0,00 % | The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SCOTTSDALE, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) ("The Joint or "the Company"), the nation's largest franchisor of chiropractic care through The Joint Chiropractic®... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 88,57 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| MIMEDX | 8,920 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Third Quarter 2024 Operating and Financial Results | Net Sales of $84 million Grew 3% Year-Over-Year for the Third QuarterThird Quarter GAAP Net Income and Earnings Per Share were $8 Million and $0.05, RespectivelyThird Quarter Adjusted EBITDA was $18... ► Artikel lesen | |
| HYPERFINE | 1,030 | 0,00 % | Hyperfine, Inc.: Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets | Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health... ► Artikel lesen | |
| ATRICURE | 33,530 | 0,00 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| BIOMERICA | 0,374 | 0,00 % | Biomerica, Inc.: Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements | IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day... ► Artikel lesen | |
| PROGYNY | 17,430 | 0,00 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| PROPHASE LABS | 0,760 | 0,00 % | ProPhase Labs, Inc.: ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 | Projections for Pharmaloz Manufacturing: Approximately $16-17 Million in Revenue, $6-7 Million in Pre-Tax Earnings for 2025 Strategic Partnership Discussions Begin for BE-Smart Esophageal Cancer... ► Artikel lesen | |
| LIFEMD | 5,765 | 0,00 % | LifeMD CEO Justin Schreiber verkauft Aktien im Wert von 129.667 US-Dollar |
ICECURE MEDICAL LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,370 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ICECURE MEDICAL LTD finden Sie auf Wallstreet Online.
